Ultrahuman launches atrial fibrillation detection via smart ring New AFib plugin monitors smart ring wearers’ heart rhythm at night, enabling those at risk of arrhythmia to track their condition. #longevity #wearables #healthtech
Longevity.Technology
Information Services
London, UK 11,124 followers
The #1 destination for daily news and insights on the fast-growth longevity market.
About us
Just how close is technology that will enable humans to have hyper-extended lifespans? Closer than you think. Our mission is to bring together innovators, researchers, insurers, policy-makers, practitioners and commentators to address the new and fast-growing science and investment category that will shape the future of both the world’s population and the global economy: LONGEVITY
- Website
-
https://www.longevity.technology
External link for Longevity.Technology
- Industry
- Information Services
- Company size
- 11-50 employees
- Headquarters
- London, UK
- Type
- Privately Held
- Founded
- 1997
- Specialties
- Organ replacement, Nanotechnology, Senescence, Genetic engineering, Drug development, Artificial intelligence, Digital health, Man machine integration, and Eldercare
Locations
-
Primary
Get directions
London, UK EC2Y 9DT, GB
Employees at Longevity.Technology
Updates
-
Cell therapy shows potential in multiple age-related diseases Longeveron Inc CEO: Lomecel-B simultaneously targets multiple aging-related processes in Alzheimer’s, age-related frailty and beyond. Wa'el Hashad #longevity #celltherapy #Alzheimers
Cell therapy shows potential in multiple age-related diseases
https://longevity.technology
-
BioXtek : Creating cutting-edge regenerative therapeutics from human birth tissue BioXtek is revolutionizing healthcare by turning once discarded birth byproducts into powerful regenerative therapies that redefine patient care. Bruce Werber, DPM, MSc, FACFAS #biotech #regenerative #therapeutics #healthcare #longevity
BioXtek: Creating cutting-edge regenerative therapeutics from human birth tissue
https://longevity.technology
-
Asceneuron SA bags $100m to advance tau-targeting Alzheimer’s drug into Phase 2 clinical trial Company’s small molecule OGA inhibitors have shown potential to improve protein aggregation in Alzheimer’s, Parkinson’s and ALS. Novo Holdings #longevity #investment #Alzheimers #biotech
Asceneuron bags $100m to advance tau-targeting Alzheimer's drug into clinical trial
https://longevity.technology
-
AniVC out of the traps with $35 million fund for pet longevity Early-stage fund will back innovative startups in Europe, Asia and the US that are focused on pets’ longevity, health and therapeutics. #investment #funding #petlongevity #petcare
Ani.VC out of the traps with $35 million fund for pet longevity
https://longevity.technology
-
OpenAI Startup Fund and Thrive Global launch AI health coaching venture Leveraging generative AI, Thrive AI Health seeks to improve healthspan and lifespan via a personalized approach to behavior change. Arianna Huffington Sam Altman #longevity #AI #investment #healthspan
OpenAI Startup Fund and Thrive Global launch AI health coaching venture
https://longevity.technology
-
Longevity: An insider’s view Guesting on the Joint Dynamics podcast, Phil Newman discusses longevity tipping points, new drugs and flipping the demographic pyramid. Andrew Cox #JointDynamics #LongevityTechnology #Podcast #LongevityEconomy #longevitytips
Longevity: An insider's view
https://longevity.technology
-
HepaRegeniX GmbH lands €15m to advance liver regeneration drug into clinical trials Company to commence clinical trials of MKK4 inhibitor shown to induce liver regeneration ‘even in severely diseased livers.’ #longevity #investment #regeneration #liver
HepaRegenix lands €15m to advance liver regeneration drug into clinical trials
https://longevity.technology
-
Predicting speed of cognitive decline in early Alzheimer’s Predictive models offer insight into cognitive decline for early Alzheimer’s patients, highlighting potential benefits of new drugs. Amsterdam UMC Pieter van der Veere #innovation #AI #digital #cognitivehealth #alzheimers
Predicting speed of cognitive decline in early Alzheimer's
https://longevity.technology
-
‘We want to build a standard here that can be accepted anywhere’ Vitalia.city CEO Niklas Anzinger on the longevity city success story – community, credibility and crypto. Próspera #longevity #biotech #technology #startups #cybernetics #genetics #biohacking #desci #crypto #web3 #acceleration #governance #networkstate #bioacc
We want to build a standard here that can be accepted anywhere
https://longevity.technology